Search results
Orangeburg breaks ground on $23 million redevelopment project aimed at revitalizing downtown
The Post and Courier· 19 hours agoDepartment of Transportation RAISE Grant as well as a $500,000 Environmental Protection Agency...
EPA has lowered the screening level for lead in soil. What that could mean for US households.
Kentucky Lantern via Yahoo News· 1 day agoThis article is republished from The Conversation under a Creative Commons license. Read the...
...Purchase, Construction Update, and the Approval of the Definitive Mining Licenses For Phases 1, 2...
Digital Journal· 6 days agoAll mining and environmental licenses/permits are approved and in-hand for the future phased, modular expansion of Santa Cruz graphite production up to 50,000 tonnes/year.
What's happening with the new Chesapeake Bay crossing
Axios· 5 days agoIt's prime summer traffic time over the Bay Bridge as DMV drivers head to the beach and shore — so...
What is the history of the Cadence land in east Henderson?
Las Vegas Review-Journal· 21 hours ago“When we were doing construction I took my kids out there all the time. I’ve worked here for 20...
Have giant humans ever existed?
Live Science via Yahoo News· 2 days agoGenetics combines with environmental factors, such as diet in early life, to determine height, with populations often growing taller over time with the...
New immunotherapy shows promise for advanced colorectal cancer in early trial
MedicalNewsToday via AOL· 5 days agoA combination of two monoclonal antibodies was effective in 61% of people with the most common form...
AbbVie's (ABBV) Skyrizi Gets FDA Nod for Ulcerative Colitis
Zacks via Yahoo Finance· 6 days agoIn recent years, there has been a surge in CD and UC cases due to genetic factors, environmental...
DOTD hopes to have top location for new Mississippi River Bridge picked out by early 2025
WVLA Baton Rouge via Yahoo News· 12 hours agoThe Department of Transportation and Development is beginning the groundwork to narrow down the top...
TREMFYA® (guselkumab) studies underscore its potential to be the only IL-23 inhibitor to offer both...
Morningstar· 5 days agoJohnson & Johnson (NYSE: JNJ) today announced positive topline results from the pivotal Phase 3 GRAVITI investigational study of TREMFYA® (guselkumab) subcutaneous ...